Study of Endostar Subcutaneous Injection in NSCLC

NCT02652234 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

NSCLC

Interventions

DRUG: Endostar
DRUG: Chemotherapy

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.